KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Short term Debt: 2009-2021

Historic Short term Debt for Charles River Laboratories International (CRL) over the last 13 years, with Dec 2021 value amounting to $2.8 million.

  • Charles River Laboratories International's Short term Debt fell 8.62% to $2.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.1 million, marking a year-over-year decrease of 8.62%. This contributed to the annual value of $2.8 million for FY2021, which is 94.43% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Short term Debt of $2.8 million as of FY2021, which was down 94.43% from $50.2 million recorded in FY2020.
  • Over the past 5 years, Charles River Laboratories International's Short term Debt peaked at $50.2 million during FY2020, and registered a low of $2.8 million during FY2021.
  • In the last 3 years, Charles River Laboratories International's Short term Debt had a median value of $38.5 million in 2019 and averaged $30.5 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Short term Debt skyrocketed by 30.27% in 2020, and later tumbled by 94.43% in 2021.
  • Over the past 5 years, Charles River Laboratories International's Short term Debt (Yearly) stood at $31.0 million in 2017, then increased by 1.35% to $31.4 million in 2018, then climbed by 22.69% to $38.5 million in 2019, then spiked by 30.27% to $50.2 million in 2020, then tumbled by 94.43% to $2.8 million in 2021.